- Home
- SGRP vs MBRX Comparison
SGRP vs MBRX Comparison
Compare SGRP & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- MBRX
- Stock Information
- Founded
- SGRP 1967
- MBRX 2015
- Country
- SGRP United States
- MBRX United States
- Employees
- SGRP N/A
- MBRX N/A
- Industry
- SGRP Business Services
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- SGRP Consumer Discretionary
- MBRX Health Care
- Exchange
- SGRP Nasdaq
- MBRX Nasdaq
- Market Cap
- SGRP 27.3M
- MBRX 23.5M
- IPO Year
- SGRP 1996
- MBRX 2016
- Fundamental
- Price
- SGRP $1.05
- MBRX $0.49
- Analyst Decision
- SGRP
- MBRX Strong Buy
- Analyst Count
- SGRP 0
- MBRX 4
- Target Price
- SGRP N/A
- MBRX $5.00
- AVG Volume (30 Days)
- SGRP 51.8K
- MBRX 5.3M
- Earning Date
- SGRP 11-14-2025
- MBRX 11-12-2025
- Dividend Yield
- SGRP N/A
- MBRX N/A
- EPS Growth
- SGRP N/A
- MBRX N/A
- EPS
- SGRP N/A
- MBRX N/A
- Revenue
- SGRP $143,501,000.00
- MBRX N/A
- Revenue This Year
- SGRP $7.22
- MBRX N/A
- Revenue Next Year
- SGRP N/A
- MBRX N/A
- P/E Ratio
- SGRP N/A
- MBRX N/A
- Revenue Growth
- SGRP N/A
- MBRX N/A
- 52 Week Low
- SGRP $0.91
- MBRX $0.25
- 52 Week High
- SGRP $2.46
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- SGRP 46.12
- MBRX 51.83
- Support Level
- SGRP $1.03
- MBRX $0.44
- Resistance Level
- SGRP $1.15
- MBRX $0.63
- Average True Range (ATR)
- SGRP 0.04
- MBRX 0.05
- MACD
- SGRP 0.00
- MBRX -0.00
- Stochastic Oscillator
- SGRP 21.42
- MBRX 30.90
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.